Three doses HPV vaccine vs control
Serious adverse events at up to 3‐year · 10‐ to 26‐year‐old males
It is very uncertain whether three doses HPV vaccine changes serious adverse events at up to 3‐year compared with control (very low certainty).
1 finding from 1 review
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV‐related… 2019 · Cochrane Headline outcomes onlyOR 1.48 [0.15, 14.46]1 study · 270 participantsVery low